Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 864509, 7 pages
http://dx.doi.org/10.1155/2015/864509
Research Article

15d-PGJ2 Reduced Microglia Activation and Alleviated Neurological Deficit of Ischemic Reperfusion in Diabetic Rat Model

1Department of Neurology, Central Hospital of Zhabei District, Shanghai 200070, China
2Department of Neurology, East Hospital, Medicine School of Tongji University, Shanghai 200120, China

Received 9 September 2015; Accepted 19 November 2015

Academic Editor: Koichiro Wada

Copyright © 2015 Lihong Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Turner, B. Lucke-Wold, N. Lucke-Wold et al., “Neuroprotection for ischemic stroke: moving past shortcomings and identifying promising directions,” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 1890–1917, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Aggarwal, J. B. Hall, C. B. McLeland, M. A. Dobrovolskaia, and S. E. McNeil, “Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy,” Advanced Drug Delivery Reviews, vol. 61, no. 6, pp. 428–437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. I. Kelly-Cobbs, R. Prakash, W. Li et al., “Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 304, no. 6, pp. H806–H815, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Y. Hassumi, V. J. Silva-Filho, J. C. Campos-Júnior et al., “PPAR-γ agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis,” International Immunopharmacology, vol. 9, no. 10, pp. 1150–1158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. S. Ola, M. I. Nawaz, H. A. Khan, and A. S. Alhomida, “Neurodegeneration and neuroprotection in diabetic retinopathy,” International Journal of Molecular Sciences, vol. 14, no. 2, pp. 2559–2572, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Li, X. Xu, D. Wang, J. Wang, Y. Wang, and J. Yu, “Microglial activation during acute cerebral infarction in the presence of diabetes mellitus,” Neurological Sciences, vol. 32, no. 6, pp. 1075–1079, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Y. Lai and K. G. Todd, “Microglia in cerebral ischemia: molecular actions and interactions,” Canadian Journal of Physiology and Pharmacology, vol. 84, no. 1, pp. 49–59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Lalancette-Hébert, G. Gowing, A. Simard, C. W. Yuan, and J. Kriz, “Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain,” The Journal of Neuroscience, vol. 27, no. 10, pp. 2596–2605, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. L. Lambertsen, B. H. Clausen, A. A. Babcock et al., “Microglia protect neurons against ischemia by synthesis of tumor necrosis factor,” The Journal of Neuroscience, vol. 29, no. 5, pp. 1319–1330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Kapadia, J.-H. Yi, and R. Vemuganti, “Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists,” Frontiers in Bioscience, vol. 13, no. 5, pp. 1813–1826, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Culman, Y. Zhao, P. Gohlke, and T. Herdegen, “PPAR-γ: therapeutic target for ischemic stroke,” Trends in Pharmacological Sciences, vol. 28, no. 5, pp. 244–249, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. N. A. Victor, E. W. Wanderi, J. Gamboa et al., “Altered PPAR-γ expression and activation after transient focal ischemia in rats,” European Journal of Neuroscience, vol. 24, no. 6, pp. 1653–1663, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S.-Y. Xu and S.-Y. Pan, “The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy,” Medical Science Monitor Basic Research, vol. 28, no. 19, pp. 37–45, 2013. View at Publisher · View at Google Scholar
  14. S. Takefuji, T. Murase, Y. Sugimura et al., “Role of microglia in the pathogenesis of osmotic-induced demyelination,” Experimental Neurology, vol. 204, no. 1, pp. 88–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. U.-K. Hanisch and H. Kettenmann, “Microglia: active sensor and versatile effector cells in the normal and pathologic brain,” Nature Neuroscience, vol. 10, no. 11, pp. 1387–1394, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. C. T. Ekdahl, Z. Kokaia, and O. Lindvall, “Brain inflammation and adult neurogenesis: the dual role of microglia,” Neuroscience, vol. 158, no. 3, pp. 1021–1029, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Ferrer and A. M. Planas, “Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra,” Journal of Neuropathology and Experimental Neurology, vol. 62, no. 4, pp. 329–339, 2003. View at Google Scholar · View at Scopus
  18. S. Faubel and C. L. Edelstein, “Caspases as drug targets in ischemic organ injury,” Current Drug Targets: Immune, Endocrine and Metabolic Disorders, vol. 5, no. 3, pp. 269–287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. P. A. Li, Q. P. He, O. Yi-Bing, B. R. Hu, and B. K. Siesjö, “Phosphorylation of extracellular signal-regulated kinase after transient cerebral ischemia in hyperglycemic rats,” Neurobiology of Disease, vol. 8, no. 1, pp. 127–135, 2001. View at Publisher · View at Google Scholar
  20. A. Bernardo, G. Levi, and L. Minghetti, “Role of the peroxisome proliferator-activated receptor-γ (PPAR-γ) and its natural ligand 15-deoxy-Δ12,14-prostaglandin J2 in the regulation of microglial functions,” European Journal of Neuroscience, vol. 12, no. 7, pp. 2215–2223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. D. V. Chistyakov, S. E. Aleshin, A. A. Astakhova et al., “Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists,” Journal of Neurochemistry, vol. 134, no. 1, pp. 113–124, 2015. View at Google Scholar
  22. M. T. Heneka and G. E. Landreth, “PPARs in the brain,” Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids, vol. 1771, no. 8, pp. 1031–1045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass, “The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation,” Nature, vol. 391, no. 6662, pp. 79–82, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Giaginis, G. Tsourouflis, and S. Theocharis, “Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury,” Current Molecular Medicine, vol. 8, no. 6, pp. 562–579, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Qin, W. Tan, Z. Zhang et al., “15d-Prostaglandin J2 protects cortical neurons against oxygen–glucose deprivation/reoxygenation injury: involvement of inhibiting autophagy through upregulation of Bcl-2,” Cellular and Molecular Neurobiology, vol. 35, no. 3, pp. 303–312, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. C. N. Koyani, W. Windischhofer, C. Rossmann et al., “15-Deoxy-Δ12,14-PGJ2 promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis,” International Journal of Cardiology, vol. 173, no. 3, pp. 472–480, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Chen, C. Liu, X. Wang, X. Li, Y. Chen, and N. Tang, “15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) promotes apoptosis of HBx-positive liver cells,” Chemico-Biological Interactions, vol. 214, no. 1, pp. 26–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Ozasa, M. Ayaori, M. Iizuka et al., “Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies,” Atherosclerosis, vol. 219, no. 1, pp. 141–150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Hamblin, L. Chang, H. Zhang, K. Yang, J. Zhang, and Y. E. Chen, “Vascular smooth muscle cell peroxisome proliferator-activated receptor-gamma mediates pioglitazone-reduced vascular lesion formation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 2, pp. 352–359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. J. Pelham, H. L. Keen, S. R. Lentz, and C. D. Sigmund, “Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 304, no. 9, pp. R690–R701, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Ding, A. C. Carrão, R. J. Wagner et al., “Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 2, pp. 474–484, 2012. View at Publisher · View at Google Scholar · View at Scopus